Skip to content

Surgical versus conservative treatment for acute grade III acromioclavicular dislocation

Surgical versus conservative treatment for acute grade III acromioclavicular dislocation. Randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-696xwzw
Enrollment
Unknown
Registered
2023-05-31
Start date
2023-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acromioclavicular joint dislocation

Interventions

This is a randomized clinical trial to be developed in a single center, with two randomized parallel groups. 18 participants will be included in each group, allocated in one of two groups (Surgical or

Sponsors

Fundação Faculdade de Medicina de São José do Rio Preto
Lead Sponsor
Fundação Faculdade de Medicina de São José do Rio Preto
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Volunteers of both genders with grade III acromioclavicular dislocation; acute acromioclavicular dislocations; adults between 18 and 65 years old; no medical contraindications for the proposed treatments; acceptance and understanding of the informed consent form

Exclusion criteria

Exclusion criteria: Acromioclavicular dislocations grades I, II, IV, V and VI; dislocation with more than 14 days of evolution; associated neurovascular injury diagnosed on physical examination; head trauma; fracture in the ipsilateral upper limb; previous diseases in the affected limb that may influence the results; medical contraindication for surgery and/or anesthesia

Design outcomes

Primary

MeasureTime frame
The function and symptoms presented by the participants with the method employed will be evaluated using the DASH questionnaire, Disabilities of the arm, shoulder and hand

Secondary

MeasureTime frame
Patient in need of surgical treatment for treatment of recurrent dislocation after surgical procedure, symptomatic deformity after conservative treatment or intractable pain;Adverse eventsThose patients with perception of cosmetic deformity will be considered with adverse events; with asymptomatic acromioclavicular instability; shoulder stiffness; other events reported by the patient;Dislocation recurrenceThose patients who, in the Zanca view, present an increase in the coracoclavicular space greater than 100% in relation to the contralateral side will be considered with recurrent dislocation after surgical treatment;UCLA-modified scores (Modified University of California at Los Angeles) will be used to assess function, satisfaction and quality of life ;SF-12 Questionnaire (Short form survey) will be used to assess quality of life after and during treatment ;Return time to activitiesThe return to pre-injury activities, such as work, sport, and usual daily activities, will be analyzed and presented according to the time elapsed between the trauma and the return, calculated in weeks ;Pain will be assessed using the Visual Analog Pain Scale (VAS) and the need for medication reported by the patient will also be analyzed

Countries

Brazil

Contacts

Public ContactOreste Carrazzone

Fundação Faculdade de Medicina de São José do Rio Preto

dr.oreste@hotmail.com+55(17)32015000

Outcome results

None listed

Source: REBEC (via WHO ICTRP)